JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
VERV
1401
DELISTED
Verve Therapeutics
VERV
| $27.5M | ﹤0.01% |
1,908,364
+119,902
| +7% | +$2.35M |
2021 Q2
7 quarters
|
|
1402
iShares Broad USD High Yield Corporate Bond ETF
USHY
$25.8B
| $27.5M | ﹤0.01% |
773,723
-165,310
| -18% | -$5.81M |
2019 Q2
15 quarters
|
|
1403
CALL
Emerson Electric
EMR
$90.9B
| $27.5M | ﹤0.01% |
315,200
+244,000
| +343% | +$21.3M |
2021 Q1
8 quarters
|
|
1404
PUT
Prudential Financial
PRU
$39.2B
| $27.5M | ﹤0.01% |
331,900
+7,100
| +2% | +$678K |
2021 Q1
8 quarters
|
|
|
DOCU
1405
CALL
DocuSign
DOCU
$13.1B
| $27.5M | ﹤0.01% |
471,000
+62,100
| +15% | +$3.7M |
2022 Q3
2 quarters
|
|
1406
Cabot Corp
CBT
$4B
| $27.4M | ﹤0.01% |
357,945
+24,321
| +7% | +$1.82M |
2013 Q2
39 quarters
|
|
|
NS
1407
DELISTED
NuStar Energy L.P.
NS
| $27.4M | ﹤0.01% |
1,752,770
+217,417
| +14% | +$3.54M |
2013 Q2
39 quarters
|
|
1408
Liberty Media Corporation Series C Common Stock
FWONK
$23.9B
| $27.4M | ﹤0.01% |
378,296
+77,534
| +26% | +$5.24M |
2014 Q3
34 quarters
|
|
|
CUK
1409
DELISTED
Carnival PLC
CUK
| $27.4M | ﹤0.01% |
2,989,709
-165,126
| -5% | -$1.54M |
2015 Q1
32 quarters
|
|
1410
NiSource
NI
$19B
| $27.3M | ﹤0.01% |
974,743
+14,187
| +1% | +$388K |
2013 Q2
39 quarters
|
|
1411
Bunge Global
BG
$20.4B
| $27.3M | ﹤0.01% |
285,285
-262,042
| -48% | -$25.5M |
2013 Q2
39 quarters
|
|
1412
Enova International
ENVA
$4.4B
| $27.2M | ﹤0.01% |
611,920
+176,313
| +40% | +$8M |
2015 Q4
29 quarters
|
|
1413
KraneShares CSI China Internet ETF
KWEB
$4.45B
| $27.2M | ﹤0.01% |
870,770
-6,115,439
| -88% | -$196M |
2017 Q2
23 quarters
|
|
1414
Ameris Bancorp
ABCB
$5.43B
| $27.2M | ﹤0.01% |
742,231
+283,307
| +62% | +$12.7M |
2014 Q1
36 quarters
|
|
1415
CALL
IBM
IBM
$209B
| $27.1M | ﹤0.01% |
206,400
-205,900
| -50% | -$27.5M |
2016 Q1
28 quarters
|
|
1416
PUT
Pfizer
PFE
$156B
| $27.1M | ﹤0.01% |
663,100
-815,600
| -55% | -$35.2M |
2013 Q2
39 quarters
|
|
|
VRE
1417
DELISTED
Veris Residential
VRE
| $27M | ﹤0.01% |
1,846,721
-395,656
| -18% | -$6.31M |
2013 Q2
39 quarters
|
|
1418
Home BancShares
HOMB
$5.72B
| $27M | ﹤0.01% |
1,244,481
+162,245
| +15% | +$3.75M |
2013 Q2
39 quarters
|
|
1419
CALL
Logitech
LOGI
$14.6B
| $27M | ﹤0.01% |
464,700
+436,800
| +1,566% | +$24.8M |
2022 Q3
2 quarters
|
|
|
MODV
1420
DELISTED
ModivCare
MODV
| $27M | ﹤0.01% |
320,572
+5,207
| +2% | +$501K |
2017 Q4
21 quarters
|
|
1421
CALL
State Street SPDR Portfolio Europe ETF
SPEU
$691M
| $26.9M | ﹤0.01% |
+600,000
| New | +$22.4M |
2023 Q1
0 quarters
|
|
1422
iShares US Infrastructure ETF
IFRA
$3.99B
| $26.9M | ﹤0.01% |
719,981
+73,944
| +11% | +$2.79M |
2022 Q2
3 quarters
|
|
|
RXDX
1423
CALL
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $26.8M | ﹤0.01% |
250,000
+46,600
| +23% | +$5.36M |
2022 Q4
1 quarter
|
|
1424
Legend Biotech
LEGN
$3.57B
| $26.8M | ﹤0.01% |
556,016
+83,615
| +18% | +$4.09M |
2020 Q2
11 quarters
|
|
|
CMA
1425
DELISTED
Comerica
CMA
| $26.8M | ﹤0.01% |
617,021
+103,375
| +20% | +$6.62M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.